NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MBD2 | hg19_v2_chr18_-_51751132_51751158 | -0.91 | 1.2e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_74212073 Show fit | 1.90 |
ENST00000441217.1
|
AC073046.25 |
|
chr19_-_14201507 Show fit | 1.04 |
ENST00000533683.2
|
sterile alpha motif domain containing 1 |
|
chr19_-_14201776 Show fit | 0.69 |
ENST00000269724.5
|
sterile alpha motif domain containing 1 |
|
chr8_+_61592073 Show fit | 0.53 |
ENST00000526846.1
|
chromodomain helicase DNA binding protein 7 |
|
chr16_+_2022036 Show fit | 0.50 |
ENST00000568546.1
|
transducin (beta)-like 3 |
|
chr1_-_22469459 Show fit | 0.49 |
ENST00000290167.6
|
wingless-type MMTV integration site family, member 4 |
|
chr18_-_72264805 Show fit | 0.46 |
ENST00000577806.1
|
long intergenic non-protein coding RNA 909 |
|
chr22_-_19419205 Show fit | 0.46 |
ENST00000340170.4
ENST00000263208.5 |
histone cell cycle regulator |
|
chr10_+_104180580 Show fit | 0.46 |
ENST00000425536.1
|
F-box and leucine-rich repeat protein 15 |
|
chr16_+_2059872 Show fit | 0.45 |
ENST00000567649.1
|
neuropeptide W |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.1 | 0.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.5 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.2 | 0.5 | GO:0061183 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) renal vesicle induction(GO:0072034) regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 0.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.5 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.4 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.0 | 0.4 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.5 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.0 | 0.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.2 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.2 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |